Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system Health Condition 2: null- Patients fit for shoulder surgeries
Conditions
Interventions
Intervention1: injection dexamethasone,injection ropivacaine: single shot of injection 0.5% ropivacaine 30 ml with 2ml of dexamethasone 8 mg to a total of 32 ml given via ultrasound guided continuous
Sponsors
Department of Anaesthesia and Intensive care
Department of Orthopaedics
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anesthesiologists (ASA) physical status I-II Age 18-65 years BMI â?? 18-30 kg/m2 of either sex Arthroscopic shoulder surgery, such as rotator cuff injury repair, recurrent shoulder dislocations, superior labrum anterior and posterior (SLAP lesion), acromioplasty, labral cyst removal
Exclusion criteria
Exclusion criteria: Patient refusing to give informed consent History of relevant drug allergy History of psychiatric illness, substance abuse Severe cardiovascular, respiratory, metabolic or neurological disease Pregnancy and lactation Coagulopathy Contralateral phrenic nerve dysfunction Infection at planned injection site Patients receiving α2 agonists for hypertensive disorders Patients on steroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of postoperative analgesia.Timepoint: Duration of postoperative analgesia, as measured (in min) from the achievement of adequate sensory block till the first bolus of 0.2% ropivacaine by PCRA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measures pain ratings over 48 hour on 0-100 VAS, total postoperative analgesic consumption, patient satisfaction, and adverse effects.Timepoint: Measures pain ratings over 24 h on 0-100 VAS, total postoperative analgesic consumption, patient satisfaction, and adverse effects. | — |
Countries
India
Contacts
Public ContactVaibhav Taneja
M.D (Anaesthesia)
Outcome results
None listed